2012 |
17β-estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brain. |
Roberta Diaz Brinton, Ph.D |
2012 |
Selective oestrogen receptor modulators differentially potentiate brain mitochondrial function. |
Roberta Diaz Brinton, Ph.D |
2012 |
Intranasal delivery of biologics to the central nervous system. |
Jeffrey J. Lochhead, PhD |
2012 |
Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors. |
Frank Porreca, PhD, Todd Vanderah, PhD |
2012 |
The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid. |
|
2012 |
Differential responses of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr) to 17β-estradiol and progesterone in hippocampal subregions that support synaptic remodeling and neurogenesis. |
Roberta Diaz Brinton, Ph.D |
2012 |
Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS |
2012 |
Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues. |
John M. Streicher, PhD |
2012 |
Mechanisms of Bv8-induced biphasic hyperalgesia: increased excitatory transmitter release and expression. |
Michael H. Ossipov, Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD |
2012 |
The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration. |
|
2012 |
A dominant negative ERβ splice variant determines the effectiveness of early or late estrogen therapy after ovariectomy in rats. |
Roberta Diaz Brinton, Ph.D |
2012 |
Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation. |
Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Todd Vanderah, PhD, Eva Varga, Ph.D. |
2013 |
Neurosteroids as regenerative agents in the brain: therapeutic implications. |
Roberta Diaz Brinton, Ph.D |
2013 |
Maintenance of mitochondrial genomic integrity in the absence of manganese superoxide dismutase in mouse liver hepatocytes. |
|
2013 |
Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain. |
Victor Hruby, Ph.D., Todd Vanderah, PhD |
2013 |
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists. |
Patrick W Mantyh, Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
2013 |
Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments. |
Roberta Diaz Brinton, Ph.D |
2013 |
Functional selectivity of 6'-guanidinonaltrindole (6'-GNTI) at κ-opioid receptors in striatal neurons. |
John M. Streicher, PhD |
2013 |
Effect of anchoring 4-anilidopiperidines to opioid peptides. |
Victor Hruby, Ph.D., Josephine Lai , Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD |
2013 |
Window of opportunity for estrogen and progestin intervention in brain aging and Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
2013 |
Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects. |
Peg Davis, Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
2013 |
Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention. |
Roberta Diaz Brinton, Ph.D |
2013 |
Development of functionally selective, small molecule agonists at kappa opioid receptors. |
John M. Streicher, PhD |
2013 |
Early intervention with an estrogen receptor β-selective phytoestrogenic formulation prolongs survival, improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
2013 |
Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities. |
Victor Hruby, Ph.D., Josephine Lai , Ph.D., Tally Largent-Milnes, PhD, Edita Navratilova, Frank Porreca, PhD, Todd Vanderah, PhD |